Four Maryland companies received a total of $800,000 in funding through TEDCO's Life Science Investment Fund (LSIF). They are:

• AsclepiX Therapeutics, a biotech company established to leverage the anti-angiogenic peptide development and the nano/microparticle technologies;
• Sonavex, which has developed the EchoSure/EchoMark system to detect clots during surgeries, earlier and more reliably than existing modalities;
• Vasoptic Medical, Inc., which leverages laser-based vascular imaging technology to solve diabetic retinopathy, deploying a portable blood flow monitor for early detection and management; and
• Gel-e, which is focused on expanding its core technology platform to develop and commercialize hemostatic medical devices. Read more

The Board of Directors of TEDCO has approved the Maryland Stem Cell Research Commission's recommendation to fund 26 new research proposals totaling $8,406,269.

The newly-funded research projects show promise for contributing to cures for a wide range of debilitating diseases and conditions, including heart failure, stroke, multiple sclerosis, vascular diseases, Parkinson's Disease, schizophrenia, autism spectrum disorders, and cancer. Read More

MERL Office Hours